NCT06593327View on ClinicalTrials.gov

NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients with Type 2 Diabetes: STRONG-DM Study

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 10, 2025

Primary Completion Date

December 10, 2027

Study Completion Date

December 15, 2027

Conditions
Type 2 DiabetesDiabetic CardiomyopathyHeart FailureCardiometabolic Diseases
Interventions
BEHAVIORAL

Intensive Prevention Strategy

Providers randomized to the intensive prevention strategy will receive notification about patients with diabetes who have high heart failure risk and recommendations for medical management, e-consultation, or referral to a cardiometabolic risk management program.

Trial Locations (1)

75209

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

Roche Diagnostics GmbH

INDUSTRY

lead

University of Texas Southwestern Medical Center

OTHER